Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
First Claim
Patent Images
1. A method of treatment of obstructive respiratory diseases by inhalative administration of a pharmaceutically suitable salt of the enantiomerically pure ester (3R,2′
- R)-3-[cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium with enantiomeric purity of 90% minimum enantiometric excess (ee), in an effective amount to a patient in need thereof.
4 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are enantiomerically pure cyclic aminoalcohol esters of arylcycloalkylhydroxycarboxylic acids with at least 90% enantiomeric excess of the (3R,2′R), (3S,2′R), (3R,2′S), or (3S,2′S) configured enantiomer.
-
Citations
22 Claims
-
1. A method of treatment of obstructive respiratory diseases by inhalative administration of a pharmaceutically suitable salt of the enantiomerically pure ester (3R,2′
- R)-3-[cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium with enantiomeric purity of 90% minimum enantiometric excess (ee), in an effective amount to a patient in need thereof.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
-
12. A method of treatment of obstructive respiratory diseases by inhalative administration of a pharmaceutically suitable salt of the enantiomerically pure ester (3S,2′
- R)-3-[cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethylpyrrolidinium with enantiomeric purity of 90% minimum enantiomeric excess (ee), in an effective amount to a patient in need thereof.
- View Dependent Claims (13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
Specification